Stay updated on Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision: v3.3.2 appears as the site revision tag, replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:55:29.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The general government funding notice about operating status was removed; otherwise the study record history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-18T07:24:22.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The two screenshots show the same Record History table with no new version data or changes to core content. Only minor UI/visual adjustments are evident.
    Difference
    0.1%
    Check dated 2025-10-27T20:56:11.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.
    Difference
    10%
    Check dated 2025-10-06T08:11:20.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Update: version bumped from v3.0.2 to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-29T04:43:11.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no substantive content changes otherwise.
    Difference
    0.6%
    Check dated 2025-09-14T22:10:36.000Z thumbnail image

Stay in the know with updates to Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial page.